LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market – Tullahoma News and Guardian



LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic Partnership to Offer Leading Clinical NGS Solution to the China Market  Tullahoma News and Guardian

ALAMEDA, Calif.–(BUSINESS WIRE)–Jan 10, 2019–LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today …



Read the full Shanghai News here

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.